Found: 148
Select item for more details and to access through your institution.
Presumed Nonalcoholic Fatty Liver Disease Among Medicare Beneficiaries With HIV, 2006–2016.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 1, p. N.PAG, doi. 10.1093/ofid/ofz509
- By:
- Publication type:
- Article
The Portrait of an Adult Liver Transplant Recipient in the United States From 1987 to 2013.
- Published in:
- JAMA Internal Medicine, 2014, v. 174, n. 8, p. 1407, doi. 10.1001/jamainternmed.2014.2903
- By:
- Publication type:
- Article
Trends in Liver Transplantation in Hepatitis C Virus-Infected Persons, United States.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Quality-of-Life Assessments and Chronic Liver Disease.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1998, v. 93, n. 7, p. 1037, doi. 10.1111/j.1572-0241.1998.00325.x
- By:
- Publication type:
- Article
The inpatient economic and mortality impact of hepatocellular carcinoma from 2005 to 2009: analysis of the US nationwide inpatient sample.
- Published in:
- Liver International, 2013, v. 33, n. 8, p. 1281, doi. 10.1111/liv.12201
- By:
- Publication type:
- Article
Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.
- Published in:
- Liver International, 2009, v. 29, n. 9, p. 1403, doi. 10.1111/j.1478-3231.2009.02060.x
- By:
- Publication type:
- Article
INTRODUCTION.
- Published in:
- Liver International, 2009, v. 29, p. 1, doi. 10.1111/j.1478-3231.2008.01948.x
- By:
- Publication type:
- Article
Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response.
- Published in:
- Liver International, 2009, v. 29, p. 3, doi. 10.1111/j.1478-3231.2008.01949.x
- By:
- Publication type:
- Article
Apnoeic–hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis.
- Published in:
- Liver International, 2008, v. 28, n. 8, p. 1080, doi. 10.1111/j.1478-3231.2008.01822.x
- By:
- Publication type:
- Article
Health-related quality of life in patients with chronic hepatitis B.
- Published in:
- Liver International, 2007, v. 27, n. 8, p. 1119, doi. 10.1111/j.1478-3231.2007.01558.x
- By:
- Publication type:
- Article
Impact of non-alcoholic fatty liver disease on chronic hepatitis B.
- Published in:
- Liver International, 2007, v. 27, n. 5, p. 607, doi. 10.1111/j.1478-3231.2007.01482.x
- By:
- Publication type:
- Article
Microarray technology in the study of obesity and non-alcoholic fatty liver disease.
- Published in:
- Liver International, 2005, v. 25, n. 6, p. 1091, doi. 10.1111/j.1478-3231.2005.01183.x
- By:
- Publication type:
- Article
Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.
- Published in:
- Liver International, 2005, v. 25, n. 4, p. 760, doi. 10.1111/j.1478-3231.2005.01117.x
- By:
- Publication type:
- Article
Association between Activity and Brain-Derived Neurotrophic Factor in Patients with Non-Alcoholic Fatty Liver Disease: A Data-Mining Analysis.
- Published in:
- Life (2075-1729), 2021, v. 11, n. 8, p. 799, doi. 10.3390/life11080799
- By:
- Publication type:
- Article
Review article: Hepatic steatosis and its associations with acute and chronic liver diseases.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 167, doi. 10.1111/apt.18059
- By:
- Publication type:
- Article
Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis ‐ prevalence, clinical impact, economic implications and management strategies.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. S1, doi. 10.1111/apt.17833
- By:
- Publication type:
- Article
Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 51, doi. 10.1111/apt.17734
- By:
- Publication type:
- Article
The combination of the enhanced liver fibrosis and FIB‐4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 12, p. 1417, doi. 10.1111/apt.17472
- By:
- Publication type:
- Article
Vigorous physical activity provides protection against all‐cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD).
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 6, p. 709, doi. 10.1111/apt.17308
- By:
- Publication type:
- Article
Editorial: let's get physical—long‐term benefits of vigorous physical activity in patients with nonalcoholic fatty liver disease. Authors' reply.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Review article: the epidemiologic burden of non‐alcoholic fatty liver disease across the world.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 6, p. 942, doi. 10.1111/apt.17158
- By:
- Publication type:
- Article
Letter: the use of Fibrosis‐4 score in primary care and diabetology practices—Occam's razor applied to advanced fibrosis screening. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 11/12, p. 1761, doi. 10.1111/apt.16091
- By:
- Publication type:
- Article
Editorial: a diabetologist's perspective on the diagnosis and monitoring of NAFLD—Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 4, p. 712, doi. 10.1111/apt.15929
- By:
- Publication type:
- Article
Clinical assessment for high‐risk patients with non‐alcoholic fatty liver disease in primary care and diabetology practices.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 3, p. 513, doi. 10.1111/apt.15830
- By:
- Publication type:
- Article
'Highly Plausible' GLP-1s Can Improve Health-Related QoL, Economic Burden of MASH.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 7, p. 7
- By:
- Publication type:
- Article
Modelling the economic and clinical burden of non‐alcoholic steatohepatitis in East Asia: Data from Hong Kong.
- Published in:
- Hepatology Research, 2020, v. 50, n. 9, p. 1024, doi. 10.1111/hepr.13535
- By:
- Publication type:
- Article
Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes.
- Published in:
- Journal of Infectious Diseases, 2015, v. 212, n. 3, p. 367, doi. 10.1093/infdis/jiv005
- By:
- Publication type:
- Article
Predicting Liver-Related Outcomes in Steatotic Liver Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 15, p. 1274, doi. 10.1001/jama.2024.0799
- By:
- Publication type:
- Article
Prevalence of metabolic dysfunction‐associated steatotic liver disease in the Middle East and North Africa.
- Published in:
- Liver International, 2024, v. 44, n. 4, p. 1061, doi. 10.1111/liv.15852
- By:
- Publication type:
- Article
The impact of fatigue on mortality of patients with non‐alcoholic fatty liver disease: Data from National Health and nutrition examination survey 2005–2010 and 2017–2018.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2646, doi. 10.1111/liv.15437
- By:
- Publication type:
- Article
Increased cancer rates in patients with chronic hepatitis C.
- Published in:
- Liver International, 2020, v. 40, n. 3, p. 685, doi. 10.1111/liv.14305
- By:
- Publication type:
- Article
Hypothetical treatment of patients with non‐alcoholic steatohepatitis: Potential impact on important clinical outcomes.
- Published in:
- Liver International, 2020, v. 40, n. 2, p. 308, doi. 10.1111/liv.14292
- By:
- Publication type:
- Article
Patient‐reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replication.
- Published in:
- Liver International, 2019, v. 39, n. 10, p. 1837, doi. 10.1111/liv.14171
- By:
- Publication type:
- Article
Trends in hospitalizations for chronic liver disease‐related liver failure in the United States, 2005‐2014.
- Published in:
- Liver International, 2019, v. 39, n. 9, p. 1661, doi. 10.1111/liv.14135
- By:
- Publication type:
- Article
Cytokine balance is restored as patient‐reported outcomes improve in patients recovering from chronic hepatitis C.
- Published in:
- Liver International, 2019, v. 39, n. 9, p. 1631, doi. 10.1111/liv.14115
- By:
- Publication type:
- Article
Prevalence and outcomes of non‐alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States.
- Published in:
- Liver International, 2019, v. 39, n. 4, p. 748, doi. 10.1111/liv.14038
- By:
- Publication type:
- Article
Predictors of nonalcoholic steatohepatitis and significant fibrosis in non‐obese nonalcoholic fatty liver disease.
- Published in:
- Liver International, 2019, v. 39, n. 2, p. 332, doi. 10.1111/liv.13983
- By:
- Publication type:
- Article
Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease.
- Published in:
- Liver International, 2019, v. 39, n. 2, p. 342, doi. 10.1111/liv.13992
- By:
- Publication type:
- Article
Viral eradication is required for sustained improvement of patient‐reported outcomes in patients with hepatitis C.
- Published in:
- Liver International, 2019, v. 39, n. 1, p. 54, doi. 10.1111/liv.13900
- By:
- Publication type:
- Article
Improvement of hepatic fibrosis and patient‐reported outcomes in non‐alcoholic steatohepatitis treated with selonsertib.
- Published in:
- Liver International, 2018, v. 38, n. 10, p. 1849, doi. 10.1111/liv.13706
- By:
- Publication type:
- Article
Response to the letter: Hepatitis C screening in opioid epidemics in the United States and societal perspectives.
- Published in:
- Liver International, 2018, v. 38, n. 7, p. 1331, doi. 10.1111/liv.13891
- By:
- Publication type:
- Article
Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 study.
- Published in:
- Liver International, 2017, v. 37, n. 12, p. 1796, doi. 10.1111/liv.13462
- By:
- Publication type:
- Article
A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ- NAFLD.
- Published in:
- Liver International, 2017, v. 37, n. 8, p. 1209, doi. 10.1111/liv.13391
- By:
- Publication type:
- Article
The value of cure associated with treating treatment-naïve chronic hepatitis C genotype 1: Are the new all-oral regimens good value to society?
- Published in:
- Liver International, 2017, v. 37, n. 5, p. 662, doi. 10.1111/liv.13298
- By:
- Publication type:
- Article
The impact of hepatitis C virus outside the liver: Evidence from Asia.
- Published in:
- Liver International, 2017, v. 37, n. 2, p. 159, doi. 10.1111/liv.13272
- By:
- Publication type:
- Article
Vaccination against hepatitis A and B in patients with chronic liver disease and type 2 diabetes: has anything changed?
- Published in:
- Liver International, 2016, v. 36, n. 8, p. 1096, doi. 10.1111/liv.13164
- By:
- Publication type:
- Article
The impact of ledipasvir/sofosbuvir on patient-reported outcomes in cirrhotic patients with chronic hepatitis C: the SIRIUS study.
- Published in:
- Liver International, 2016, v. 36, n. 1, p. 42, doi. 10.1111/liv.12886
- By:
- Publication type:
- Article
The outcomes of adult liver transplants in the United States from 1987 to 2013.
- Published in:
- Liver International, 2015, v. 35, n. 8, p. 2036, doi. 10.1111/liv.12779
- By:
- Publication type:
- Article
The impact of hepatocellular carcinoma diagnosis on patients' health‐related quality of life.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 18, p. 6273, doi. 10.1002/cam4.4166
- By:
- Publication type:
- Article
Gamma glutamyltransferase and risk of dementia in prediabetes and diabetes.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-63803-0
- By:
- Publication type:
- Article